Magnus Pfaffenbach, Philippe N Bolduc, Zhili Xin, Fang Gao, Ryan Evans, Terry Fang, Jayanth V Chodaparambil, Kate L Henry, Pei Li, Steven Mathieu, Claire Metrick, Jorge A Vera Rebollar, Rong-Fang Gu, Christie-Ann Mccarl, John Silbereis, Emily A Peterson
Interleukin receptor associated kinase 4 (IRAK4) plays an important role in innate immune signaling through Toll-like and interleukin-1 receptors and represents an attractive target for the treatment of inflammatory diseases and cancer. We previously reported the development of a potent, selective, and brain-penetrant imidazopyrimidine series of IRAK4 inhibitors. However, lead molecule BIO-7488 ( 1 ) suffered from low solubility which led to variable PK, compound accumulation, and poor in vivo tolerability...
May 2, 2024: Journal of Medicinal Chemistry